EUVIMEDEUVIMED entdecken
Crossref

AB027. SOH26AB_0416. Is contrast-enhanced mammography or breast MRI superior in assessing treatment response in patients with breast cancer following neoadjuvant chemotherapy?—an evidence-based approach

Mary Byrne, Cressida Brennan

Mesentery and Peritoneum · 2026-04 · 10 · AB027-AB027

DOI: 10.21037/map-26-ab027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mesentery and Peritoneum, 2026-04. Verfasst von Mary Byrne und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Byrne, M., & Brennan, C. (2026). AB027. SOH26AB_0416. Is contrast-enhanced mammography or breast MRI superior in assessing treatment response in patients with breast cancer following neoadjuvant chemotherapy?—an evidence-based approach. Mesentery and Peritoneum, 10, AB027-AB027. https://doi.org/10.21037/map-26-ab027

Vancouver

Byrne M, Brennan C. AB027. SOH26AB_0416. Is contrast-enhanced mammography or breast MRI superior in assessing treatment response in patients with breast cancer following neoadjuvant chemotherapy?—an evidence-based approach. Mesentery and Peritoneum. 2026;10:AB027-AB027. doi:10.21037/map-26-ab027

BibTeX
@article{Byrne2026,
  author = {Byrne, Mary and Brennan, Cressida},
  title = {AB027. SOH26AB_0416. Is contrast-enhanced mammography or breast MRI superior in assessing treatment response in patients with breast cancer following neoadjuvant chemotherapy?—an evidence-based approach},
  journal = {Mesentery and Peritoneum},
  year = {2026},
  volume = {10},
  pages = {AB027--AB027},
  doi = {10.21037/map-26-ab027}
}
Kostenlos starten →